News
The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...
Clinical Trials Arena on MSN18h
FDA clears Grifols’ application for dry eye disease treatmentThe US Food and Drug Administration (FDA) has cleared Grifols' investigational new drug (IND) application to initiate a Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback